Introduction
============

According to the World Health Organization, cardiovascular diseases (CVD) are the world's leading cause of death, accounting for 17.5 million deaths annually, of which ischemic heart disease caused 7.3 million deaths ([@r1]). In Croatia, myocardial infarction (MI) is the third leading cause of death ([@r2]). Although numerous studies on MI have been conducted, its etiology remains largely unknown ([@r3]).

Circadian rhythms are associated with many cardiovascular parameters ([@r4]). Human physiologic activities and state during illness are under the control of circadian rhythm, which controls physiology at multiple levels, from gene expression to complex behaviors ([@r5]-[@r7]). The effect of circadian rhythm on acute MI has been the subject of considerable scientific interest ([@r8]). Sleep is one of the main requirements for the normal psychophysical functioning of every person ([@r9]), especially needed in situations of physical and psychological stress. Sleep disorders are common phenomena in modern society with the prevalence rising to 11.9%, and they are associated with vascular outcomes such as MI ([@r10]). Humans can be categorized into different circadian phenotypes (chronotypes) depending on their preferred time of sleep and wakefulness ([@r11]).

One study showed that daytime sleepiness was an independent risk factor for cardiovascular events ([@r12]), but there are no studies regarding chronotype as a risk factor for MI or CVD. There is little research done regarding this issue, and there are only a few studies in the population of MI patients ([@r13], [@r14]). Some cardiovascular risk factors, such as diabetes and hypertension, are associated with chronotype and sleep ([@r13]), while diabetes, smoking, and reinfarction can modify the circadian rhythm ([@r15]). Circadian clocks are altered in animal models with increased CVD risk, including aging, diet-induced obesity, diabetes, hypertension, simulated shift work, and ischemia ([@r16]). Circadian desynchrony of the body from its environment, either through rotating shift-work schedules or genetic alteration, augments the development of CVD ([@r16]).

Therefore, we hypothesized that MI might be associated with chronotype and daytime sleepiness in humans. To test the hypothesis, we performed a case-control study on a population of MI patients in comparison with a control population.

Materials and Methods
=====================

Participants
------------

Patients with MI were hospitalized at the Department of Cardiovascular Diseases and Intensive Care, Osijek University Hospital Centre in Osijek, Croatia.

Thygesen *et al*. defined MI by the presence of at least two of the following: typical increase of biochemical marker of myocardial necrosis -- cardiac troponin T (above the 99^th^ percentile), ischemic chest pain symptoms lasting for more than 30 minutes, and electrocardiography (ECG) changes indicative of ischemia (ST-segment elevation or depression) ([@r17]). Patients were excluded from this study if they did not meet the above criteria or if they had a percutaneous coronary intervention or coronary artery bypass grafting.

The control group consisted of 200 healthy sex- and age-matched participants, whose medical documentation did not show any history of CVD. They were selected by their own primary care physician. We excluded any patient relatives from the control group because, according to large studies, approximately 50% of the chronotype features are estimated to be heritable ([@r18], [@r19]).

The study was approved by the Ethics Committee of the Faculty of Medicine, Josip Juraj Strossmayer University of Osijek (No. 2158-61-07-12-21) and by the Ethics Committee of the Osijek University Hospital Centre (No. 25-1:3160-3/2012). The study was conducted according to the Declaration of Helsinki and its amendments. A written informed consent was obtained from all study participants.

Questionnaires
--------------

Systematic information on the past and present medical history was collected from all participants. The questionnaire included questions on age, education, employment, caffeine consumption, history of smoking, family history of MI, former CVD, hypertension, dyslipidemia, respiratory diseases, diabetes mellitus types 1 and 2, thyroid gland diseases, kidney and liver diseases. Hypertension was defined as a history of hypertension of more than two years requiring initiation of antihypertensive therapy prescribed by primary physicians. Dyslipidemia was defined as having a reported history of elevated fasting concentration of total cholesterol or triglycerides. Diabetes mellitus was defined as reported diabetes or receiving oral hypoglycemic agent treatment or insulin treatment. Positive family history of CVD was defined as evidence of coronary artery disease in first-degree relatives before 60 years of age, such as a history of MI, coronary artery bypass surgery, and angina pectoris. Former CVD was defined as a reported history of angina pectoris, MI, arrhythmia or stroke in the patient group. All given information was checked in the patient medical records.

Chronotype was assessed with the Morningness-Eveningness Questionnaire (MEQ) in the hospital after the patient medical condition had been stabilized ([@r20], [@r21]). MEQ classifies participants scored between 59 and 86 as morning types, those scored between 42 and 58 as intermediate types, and those scored 16-41 as evening types. The scores were added, and the sum was converted into a three-point MEQ scale.

Daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS, contact information and permission to use: Mapi Research Trust, Lyon, France) ([@r22], [@r23]). Participants were asked how often would they say they doze off or fall asleep in the following situations: sitting and reading, watching TV, sitting inactive in a public place, as a passenger in a car for an hour without break, lying down to rest in the afternoon, sitting and talking to someone, sitting quietly after lunch without alcohol, and in a car while stopped for a few minutes in the traffic. For each of these eight situations, responses were recorded on a scale of 0 to 3 and coded as follows: 0 = never doze, 1 = slight chance, 2 = moderate chance, and 3 = high chance. The ESS score for each participant was simply the sum of the results for their eight responses (range 0-24), and the sum was converted into four types of daytime sleepiness.

Data analyses
-------------

Data were expressed as absolute frequencies with percentages, means with standard deviations (SD), and medians with interquartile range (IQR), where appropriate. Mann-Whitney U test was used to test differences between disease status and chronotype and daytime sleepiness. The analyses were performed separately for women and men because of the sex difference in cardiovascular morbidity and mortality and the differential self-reporting of sleep habits between women and men supported in previous studies ([@r12]). Risk factors for CVD such as smoking, hypertension and dyslipidemia were compared with the MEQ and ESS scores by Pearson χ^2^-tests. The level of statistical significance was set at p\<0.05, and all significant values were assessed after Bonferroni correction for the number of independent hypotheses tested. All analyses were performed using Statistica 12 (StatSoft, Inc., version 12, Tulsa, OK, USA) system for Windows.

Results
=======

Demographic and general characteristics of the study sample are summarized in [Table 1](#t1){ref-type="table"}.

###### Demographic and general characteristics of all study participants according to groups

  Variable                Patients        Controls                       
  ----------------------- --------------- -------------- --------------- -----------
  Male (n=114)            Female (n=86)   Male (n=104)   Female (n=96)   
  Age (yrs), mean (SD)    64 (12)         69 (12)        62 (13)         62 (13)
  Smoking:                n (%)           n (%)          n (%)           n (%)
    non-smoker            41 (35.9)       58 (67.4)      70 (67.3)       81 (84.4)
    smoker                25 (21.9)       16 (18.6)      26 (25)         13 (13.5)
    former smoker         48 (42.2)       12 (13.9)      8 (7.7)         2 (2.1)
  Education:                                                             
    elementary            19 (16.7)       51 (59.3)      16 (15.4)       37 (38.5)
    secondary             77 (67.5)       29 (33.8)      70 (67.3)       44 (45.8)
    college/university    18 (15.8)       6 (6.9)        18 (17.3)       15 (15.7)
  Work status:                                                           
    employed              25 (21.9)       7 (8.2)        30 (28.9)       27 (28.1)
    unemployed            11 (9.7)        12 (13.9)      7 (6.7)         6 (6.3)
    retired               78 (68.4)       67 (77.9)      67 (64.5)       63 (65.6)
  Caffeine consumption:                                                  
    yes                   99 (86.8)       72 (83.7)      82 (78.9)       67 (69.8)
    no                    15 (13.2)       14 (16.3)      22 (21.1)       29 (30.2)

Numerical variables are presented as mean (SD), and categorical variables as number (percentage)

The mean age of the study population was 64±13 years, and 54.5% were males.

In female patients and controls, a significant difference was found in smoking and age (χ^2^=103.9, df=76, p=0.018 and χ^2^=129.8, df=74, respectively; p\<0.001), while there was no significant difference in smoking and age in male patients and controls (χ^2^=89.9, df=88, p=0.421 and χ^2^=89.5, df=88; p=0.435). The prevalence of cardiovascular risk factors among study participants is shown in [Table 2](#t2){ref-type="table"}.

###### Prevalence of cardiovascular risk factors among study participants

  Characteristic                                Patients        Controls       p value                     
  --------------------------------------------- --------------- -------------- --------------- ----------- -------------
  Male (n=114)                                  Female (n=86)   Male (n=104)   Female (n=96)               
  n (%)                                         n (%)           n (%)          n (%)                       
  Hypertension                                  57 (50)         50 (58.1)      27 (25.9)       32 (33.3)   **\<0.001**
  Dyslipidemia                                  9 (7.9)         17 (19.8)      9 (8.7)         14 (14.6)   **0.048**
  Respiratory disease                           2 (1.8)         0              3 (2.9)         5 (5.2)     0.772
  Diabetes mellitus type 1                      1 (0.9)         1 (1.2)        2 (1.9)         0           0.886
  Diabetes mellitus type 2                      26 (22.8)       18 (20.9)      0               0           **\<0.001**
  Thyroid gland disease                         2 (1.8)         6 (6.9)        0               6 (6.3)     0.612
  Kidney disease                                4 (3.5)         11 (12.8)      7 (6.7)         5 (5.2)     0.910
  Liver disease                                 1 (0.9)         9 (10.5)       4 (3.9)         5 (5.2)     0.481
  Positive family history of CVD                29 (25.4)       18 (20.9)      12 (11.5)       15 (15.6)   0.754
  History of former CVD                         82 (71.9)       61 (70.9)      7 (6.7)         7 (7.3)     0.221
  Myocardial infarction                         37 (32.5)       20 (23.3)      0               0           \-
  Other (arrhythmia, angina pectoris, stroke)   45 (39.5)       41 (47.7)      7 (6.7)         7 (7.3)     \-
  None                                          32 (28.1)       25 (29.1)      97 (93.3)       89 (92.7)   \-

p values are for MI patients *versus* controls. Family history of cardiovascular disease (CVD) was defined as evidence of coronary artery disease in first-degree relatives before 60 years of age. History of former CVD was defined as reported history of angina pectoris, myocardial infarction, arrhythmia or stroke in patient group; variables are presented as frequency (percentage)

Between-group comparisons revealed that three chronotype groups and three ESS groups were similar according to age and gender. Half (50.5%) of the MI patients were of intermediate chronotype, while only a small part (0.5%) was of evening chronotype ([Table 3](#t3){ref-type="table"}). There was no significant difference between patients and controls in daytime sleepiness (5 (IQR, 4-7.5) *vs*. 6 (IQR, 3-8), Z=0.11; p=0.912) ([Table 4](#t4){ref-type="table"}). There was no statistically significant difference in the ESS and MEQ scores between genders in patient and control groups.

###### Chronotype distribution among participants

  -----------------------------------------------------------------------
              Evening type\   Neither type\   Morning type\   p value\*
              (score 16-41)   (score 42-58)   (score 59-86)   
  ----------- --------------- --------------- --------------- -----------
  Patients    1 (0.5%)        101 (50.5%)     98 (49%)        0.601

  Controls    2 (1%)          101 (50.5%)     97 (48.5%)      

  p value\*   0.157           **0.006**       0.078           
  -----------------------------------------------------------------------

\*Mann-Whitney U test

###### Distribution of daytime sleepiness among participants

  -----------------------------------------------------------------------------------------------------------
              Normal sleepiness\   Mild sleepiness\   Moderate sleepiness\   Severe sleepiness\   p value\*
              (score 0-10)         (score 11-14)      (score 15-18)          (score 19-24)        
  ----------- -------------------- ------------------ ---------------------- -------------------- -----------
  Patients    182 (91%)            18 (9%)            0                      0                    0.912

  Controls    177 (88.5%)          20 (10%)           3 (1.5%)               0                    

  p value\*   0.510                0.795              \-                     \-                   
  -----------------------------------------------------------------------------------------------------------

\*Mann-Whitney U test

A significant difference was found in female patients of intermediate chronotype and diabetes mellitus type 2 (χ^2^=21.60, df=12; p=0.042), as well as in the ESS score of normal sleepiness and age (Z=1.99; p=0.044). The reference range of normal daytime sleepiness score is 0-10. Normal daytime sleepiness had a protective effect on the CVD risk factors in male patients, such as hypertension (OR, 0.81 (95% CI, 0.04-0.37); p=0.012), but not in female patients and control groups.

Discussion
==========

In this case-control study, we found no association of chronotype and daytime sleepiness with MI, but we did find an association with some cardiovascular risk factors such as hypertension and diabetes mellitus, which might lead to MI.

Many studies suggested gender-related differences in sleep, chronotype, and CVD ([@r12], [@r19], [@r24], [@r25]). We examined gender differences in the ESS and MEQ scores in the two groups, but we found none. This may have been due to the high mean age (\>60) of our study population; according to Roenneberg *et al.* and Roenneberg and Merrow ([@r26], [@r27]), after around 50 years of age, gender-related differences in chronotype and CVD disappear ([@r26]-[@r28]). It is considered that estrogens have a cardioprotective effect, and older adults go to sleep earlier than they used to go while they were younger, so they become earlier chronotype ([@r26]-[@r28]).

The ESS score was included to assess daytime sleepiness because sleep is an important modulator of cardiovascular and metabolic function ([@r14]). Ahmed *et al.* ([@r29]) report that the ESS score is a good predictive factor for obstructive sleep apnea, which has a very high incidence in MI patients, so that it might be associated with MI. Our results, with no association of daytime sleepiness with MI, are in concordance with the results of Boden-Albala *et al.* ([@r14]).

Some studies showed an association between diabetes, hypertension, smoking, and reinfarction with chronotype and daytime sleepiness ([@r13], [@r15]). Our finding of a difference in intermediate chronotype and diabetes mellitus type 2 in female patients is important because of the influence of metabolic syndromes on circadian rhythm and CVD. Diabetes type 2 increases the risk of CVD ([@r13], [@r30]). Metabolic syndromes, diabetes mellitus type 2, dyslipidemia, and smoking were not associated with ESS score in our study and the study by Whitney *et al.* ([@r31]), whereas other studies found an association ([@r15], [@r32]). We found no association of evening chronotype with hypertension and diabetes mellitus type 2 in our study, in contrast to the study by Merikanto *et al.* ([@r13]). Many studies showed that evening chronotype was associated with lower HDL cholesterol levels, metabolic syndrome, and higher stress hormones ([@r13], [@r33]-[@r35]). Thus, evening chronotype is associated with metabolic risk factors that predispose to CVD, which is in accordance with our results.

An association of ESS with stroke and vascular events was found in the NOMAS study ([@r14]). Although daytime sleepiness and chronotype for itself are not significant risk factors for MI, ESS and MEQ are associated with risk factors for CVD. Desynchronization of the circadian system may contribute to metabolic syndrome and complications such as dyslipidemia, glucose intolerance, hypertension, diabetes mellitus type 2, and CVD ([@r36]).

A limitation of the study was the use of questionnaires because all answers given by the participants referring to chronotype and daytime sleepiness might be a subjective evaluation of the circadian rhythms. The assessment could be more objective if taken by digital recording sleep duration and quality. Another limitation of the study was its sample size. To obtain sufficient power, larger and multicenter studies are needed. For participants in control groups, there is a risk of developing some cardiovascular events, such as angina pectoris or MI.

We found no evidence for chronotype and daytime sleepiness to be directly associated with MI, while some cardiovascular risk factors such as age, dyslipidemia, diabetes mellitus, and smoking might be associated with MEQ or ESS. It is hard to predict developing MI or some other major cardiovascular events based just on the MEQ or ESS score.
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